Retatrutide (LY3437943) represents a major advance in this direction as a synthetic peptide designed to simultaneously activate GLP-1R, GIPR, and GCGR [2,3]
In obesity, Novos Wegovy (semaglutide injection) was approved in 2021, however uptake has been hindered by access limitations, with no Medicare coverage and limited coverage among commercial plans
They identify contraindications, monitor adverse effects, and alter medication as the body responds
The easiest way to obtain L-carnitine is from red meat, which is why people who don't eat red meat often suffer from L-carnitine deficiency
If met with success, this may provide impetus for further investment and research into utilising other types of peptides, not only to compete with current weight loss drugs available, but for other conditions and diseases that render themselves treatable through peptide agonists
Thankfully in the last 50-100 years, there have been numerous discoveries to help with alcohol withdrawal at all stages